Who owns TVARDI THERAPEUTICS INC?
- Ticker: TVRD
- CUSIP Number: 140755307
Tip: Access positions for across all investors
Analyze quarterly positions in Tvardi Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Tvardi Therapeutics stock
Who bought or sold TVARDI THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Slate Path Capital | 704k | $3.0M | 0% | Dec 2025 |
|
| Vanguard Group | 425k | $1.8M | 1% | Dec 2025 |
|
| BlackRock | 388k | $1.2M | -1% | Mar 2026 |
|
| Vanguard Capital Management | 345k | $1.1M | 100% | Mar 2026 |
|
| American Financial Group | 224k | $711k | 0% | Mar 2026 |
|
| Geode Capital Management | 182k | $580k | 16% | Mar 2026 |
|
| State Street Corporation | 116k | $497k | 84% | Dec 2025 |
|
| Renaissance Technologies | 105k | $449k | 246% | Dec 2025 |
|
| Silvercrest Asset Management Group | 101k | $434k | 352% | Dec 2025 |
|
| Morgan Stanley | 73k | $232k | -14% | Mar 2026 |
|
| Duncan Williams Asset Management | 63k | $201k | -22% | Mar 2026 |
|
| UBS Group | 51k | $162k | 42% | Mar 2026 |
|
| Northern Trust | 48k | $206k | 13% | Dec 2025 |
|
| Vanguard Fiduciary Trust | 47k | $149k | 100% | Mar 2026 |
|
| Farallon Capital Management | 43k | $186k | 0% | Dec 2025 |
|
| AQR Capital Management | 42k | $127k | 100% | Mar 2026 |
|
| Wintrust Financial Corporation | 36k | $115k | 100% | Mar 2026 |
|
| Vanguard Portfolio Management | 34k | $108k | 100% | Mar 2026 |
|
| Squarepoint Ops | 33k | $104k | -37% | Mar 2026 |
|
| Goldman Sachs Group | 24k | $76k | -28% | Mar 2026 |
|
| Russell Investments | 23k | $74k | 46% | Mar 2026 |
|
| Quadrature Capital | 21k | $90k | 100% | Dec 2025 |
|
| Bank of New York Mellon | 17k | $55k | -4% | Mar 2026 |
|
| XTX Topco | 13k | $55k | 100% | Dec 2025 |
|
| Charles Schwab Investment Management | 12k | $51k | -23% | Dec 2025 |
|
| SRS Capital Advisors | 8.3k | $27k | -1% | Mar 2026 |
|
| Barclays | 8.3k | $36k | 25% | Dec 2025 |
|
| FMR | 6.6k | $28k | -92% | Dec 2025 |
|
| Vanguard Global Advisers | 3.4k | $11k | 100% | Mar 2026 |
|
| Rhumbline Advisers | 3.2k | $10k | 4% | Mar 2026 |
|
| Deutsche Bank Aktiengesellschaft | 3.0k | $9.6k | 0% | Mar 2026 |
|
| New York State Common Retirement Fund | 3.0k | $9.5k | 0% | Mar 2026 |
|
| Tower Research Capital | 2.5k | $11k | 615% | Dec 2025 |
|
| Mirae Asset Global Etfs Holdings | 2.4k | $7.5k | 3% | Mar 2026 |
|
| Wells Fargo & Company | 2.3k | $7.2k | -62% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 1.4k | $4.5k | 13% | Mar 2026 |
|
| Simplex Trading | 1.4k | $6.1k | -53% | Dec 2025 |
|
| Police & Firemen's Retirement System of New Jersey | 916.00 | $2.9k | 0% | Mar 2026 |
|
| Pnc Financial Services | 519.00 | $1.7k | 77% | Mar 2026 |
|
| Legal & General Group | 421.00 | $1.3k | 0% | Mar 2026 |
|
| Summit Investment Advisors | 349.00 | $1.1k | 0% | Mar 2026 |
|
| Citigroup | 276.00 | $897.000000 | 100% | Mar 2026 |
|
| Group One Trading | 214.00 | $680.990800 | 88% | Mar 2026 |
|
| CWM | 206.00 | $1.0k | 4020% | Dec 2025 |
|
| Sterling Capital Management | 162.00 | $514.998000 | -45% | Mar 2026 |
|
| Hanson McClain Advisors | 141.00 | $607.005000 | 642% | Dec 2025 |
|
| Jones Financial Companies, L.L | 125.00 | $538.000000 | 400% | Dec 2025 |
|
| GAMMA Investing | 89.00 | $283.002200 | 100% | Mar 2026 |
|
| Royal Bank of Canada | 85.00 | $0 | -97% | Mar 2026 |
|
| EverSource Wealth Advisors | 67.00 | $212.999700 | 1240% | Mar 2026 |
|
| Essential Partners | 60.00 | $190.998000 | 100% | Mar 2026 |
|
| IFP Advisors | 36.00 | $114.001200 | 500% | Mar 2026 |
|
| Advisor Group Holdings | 29.00 | $123.000600 | 0% | Dec 2025 |
|
| LRI Investments | 27.00 | $86.000400 | 0% | Mar 2026 |
|
| Farther Finance Advisors | 23.00 | $69.000000 | 100% | Mar 2026 |
|
| McIlrath & Eck | 20.00 | $64.000000 | 0% | Mar 2026 |
|
| Harbour Investments | 15.00 | $48.000000 | 0% | Mar 2026 |
|
| MAI Wealth Advisors | 14.00 | $45.000200 | 40% | Mar 2026 |
|
| Leonteq Securities | 12.00 | $38.000400 | 0% | Mar 2026 |
|
| Rothschild Investment | 12.00 | $38.000400 | 100% | Mar 2026 |
|
| Root Financial Partners | 10.00 | $32.000000 | 100% | Mar 2026 |
|
| True Wealth Design | 9.00 | $28.999800 | 100% | Mar 2026 |
|
| Wealth Preservation Advisors | 8.00 | $25.000000 | 100% | Mar 2026 |
|
| International Assets Investment Management | 6.00 | $18.000000 | 0% | Mar 2026 |
|
| SBI Securities | 5.00 | $16.000000 | 25% | Mar 2026 |
|
| Truvestments Capital | 4.00 | $13.000000 | 0% | Mar 2026 |
|
| Sound Income Strategies | 2.00 | $6.000000 | 100% | Mar 2026 |
|
| Larson Financial Group | 2.00 | $9.000000 | 100% | Dec 2025 |
|
| SJS Investment Consulting | 1.00 | $4.000000 | 100% | Mar 2026 |
|
| Fifth Third Bancorp | 1.00 | $3.000000 | 100% | Mar 2026 |
|
| Brian McDonald | 1.00 | $4.000000 | 0% | Dec 2025 |
|
Who sold out of Tvardi Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Parkman Healthcare Partners | Sep 2025 | 65k | $2.5M |
| Jane Street | Dec 2025 | 47k | $204k |
| Citadel Advisors | Dec 2025 | 22k | $93k |
| Hrt Financial | Dec 2025 | 11k | $47k |
| Two Sigma Investments | Dec 2025 | 11k | $45k |
| MetLife Investment Advisors | Sep 2025 | 2.8k | $110k |
| Caption Management | Sep 2025 | 2.4k | $94k |
| Diadema Partners | Sep 2025 | 2.2k | $85k |
| Jpmorgan Chase & Co | Sep 2025 | 1.9k | $75k |
| California State Teachers Retirement System | Dec 2025 | 331.00 | $1.4k |
| Amalgamated Bank | Dec 2025 | 169.00 | $1.0k |
| Wellington Grp | Dec 2025 | 100.00 | $430.000000 |
| Cornerstone Planning Group | Dec 2025 | 1.00 | $4.000000 |
| Front Row Advisors | Dec 2025 | 1.00 | $4.000000 |